Slingshot members are tracking this corporate initiative:
Novartis (NVS) Acquires Selexys for $665MM to Expand Portfolio for Blood Disorders
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date: Nov 21, 2016 Projected Implementation: Q1, 2017 Relevance Tracked Until: Q1, 2019
Don’t see a project related to the strategic initiative you care about?
Related Keywords Acquisition, Blood Disorders, Blood Diseases, Inflammatory Disorders